Both medicines are usually used for same disease known as Irritable bowel syndrome. It is basically abdominal pain and discomfort with altered bowel habits that are not explained by any other mechanical, biochemical, or inflammatory cause. Irritable bowel syndrome affects 10 to 15 percent of the U.S. population to some …
Read More »Hydrocodone vs. Oxycodone Side effects, potency, Pain Relief
Read about Hydrocodone vs. Oxycodone Side effects, potency, Pain Relief. Hydrocodone VS. Oxycodone side effects, Potency and Nausea. Hydrocodone and Oxycodone are drugs that are used to treat extreme pain. These are the most popular opioid or narcotic analgesics prescribed for pain relief. Both are available only with a prescription …
Read More »HPV Vaccine for Men: Side Effects, Risks, Pros and Cons
Both men and women can have Human papillomavirus (HPV). HPV causes cervical cancer in women and genital warts in men. The HPV vaccine effectively prevents infection with the HPV types responsible for most cervical cancers and can also prevent genital warts. Human papillomavirus also called HPV is the most widespread …
Read More »How Long Xanax Withdrawal Symptoms Last
Learn what are Xanax Withdrawal Symptoms, how long Xanax withdrawal symptoms last and why first few hour of quiting Xanax (alprazolam) should be critical monitored by the physician. Xanax (alprazolam) is a benzodiazepine class of drugs that reduce the over-activity in the brain and central nervous system by mounting the …
Read More »Darzalex/Daratumumab Side effects, Cost, Dosage for Multiple Myeloma
Darzalex/daratumumab side effects, cost, dosage for multiple myeloma. Darzalex is marketed by Janssen Biotech of Horsham, Pennsylvania. FDA approved new drug Darzalex for patients suffering from multiple myeloma on November 16, 2015. Daratumumab is active ingredient of this drug. FDA indicated this drug for treatment of patients with multiple myeloma who have received …
Read More »Orkambi Price, Side effects, Dosage for Cystic Fibrosis Treatment
Orkambi, breakthrough drugs for Cystic Fibrosis treatment was approved by FDA approved in 2015. Orkambi is orally-delivered medicine in the form of fully co-formulated tablets i.e. a combination therapy that contains two drugs lumacaftor and ivacaftor. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) is a protein that is responsible for regulating …
Read More »Tagrisso/osimertinib side effects, cost, dosage for lung cancer
Tagrisso/osimertinib side effects, cost, dosage for lung cancer.Tagrisso is marketed by Astra Zeneca Pharmaceuticals based in Wilmington, Delaware. FDA approves new pill Tagrisso/osimertinib to treat certain patients with non-small cell lung cancer on November 13, 2015. FDA has approved Tagrisso (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic …
Read More »Nucala/Mepolizumab Side effects, Cost, Dosage for Asthma
Nucala/Mepolizumab Side effects, Cost, Dosage for Asthma. Nucala is marketed by GSK. Nucala mepolizumab is approved by FDA on 4th November 2015.Nucala mepolizumab is an interleukin-5 adversary monoclonal antibody (IgG1 kappa) demonstrated for the extra support or add-on treatment of patients with serious eosinophilic asthma. Nucala is a physician recommended …
Read More »Yondelis/Trabectedin Side effects, Cost, Dosage for Leiomyosarcoma and Liposarcoma
Yondelis/Trabectedin Side effects, Cost, Dosage for Leiomyosarcoma and Liposarcoma.Yondelis is marketed by Janssen Products of Raritan, New Jersey. yondelis for Leiomyosarcoma and Liposarcoma. Yondelis/trabectedin is first approved by FDA on 23rd October 2015.Yondelis trabectedin is chemotherapy for the treatment of particular type of soft tissue sarcomas (STS) – liposarcoma and leiomyosarcoma – …
Read More »Strensiq/Asfotase Alfa Side effects, Cost, Dosage for Hypophosphatasia
Strensiq/Asfotase Alfa Side effects, Cost, Dosage for Hypophosphatasia. Strensiq is marketed by Alexion pharmaceuticals. Strensiq is approved by FDA on 23rd October 2015.Its active ingredient is asfotase alfa.Strensiq asfotase alfa is used as the initially endorsed treatment for perinatal, infantile and juvenile onset hypophosphatasia (HPP). HPP is an uncommon, hereditary, progressive, …
Read More »